Net Loss of Transgene Biotek reported to Rs 0.27 crore in the quarter ended March 2024 as against net loss of Rs 1.47 crore during the previous quarter ended March 2023. Sales reported to Rs 0.05 crore in the quarter ended March 2024. There were no Sales reported during the previous quarter ended March 2023.For the full year,net loss reported to Rs 0.66 crore in the year ended March 2024 as against net loss of Rs 6.01 crore during the previous year ended March 2023. Sales rose 283.33% to Rs 0.23 crore in the year ended March 2024 as against Rs 0.06 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales0.050 0 0.230.06 283 OPM %-540.000 --265.22-1766.67 - PBDT-0.25-0.23 -9 -0.56-1.06 47 PBT-0.27-1.47 82 -0.66-6.01 89 NP-0.27-1.47 82 -0.66-6.01 89 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 30 May 2024Powered by Capital Market - Live News

Net Loss of Transgene Biotek reported to Rs 0.12 crore in the quarter ended December 2023 as against net loss of Rs 1.38 crore during the previous quarter ended December 2022. Sales reported to Rs 0.05 crore in the quarter ended December 2023. There were no Sales reported during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales0.050 0 OPM %-200.000 - PBDT-0.10-0.14 29 PBT-0.12-1.38 91 NP-0.12-1.38 91 Powered by Capital Market - Live News

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Transgene Biotek announced that the 33th Annual General Meeting (AGM) of the company will be held on 30 December 2023.Powered by Capital Market - Live News